Evidence map›Paper›PMID 24932861›Full record

ArticlePloS one2014

Underpinning sustainable vector control through informed insecticide resistance management.

Edward K Thomsen, Clare Strode, Kay Hemmings, Angela J Hughes, Emmanuel Chanda, Mulenga Musapa, Mulakwa Kamuliwo, Faustina N Phiri, Lucy Muzia, Javan Chanda and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Pyrethroid and Carbamate Resistance inThe American journal of tropical medicine and hygiene · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Edward K ThomsenVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Clare StrodeVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Kay HemmingsVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Angela J HughesVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Emmanuel ChandaNational Malaria Control Centre, Lusaka, Zambia.
Mulenga MusapaZambia Integrated Systems Strengthening Program, Abt Associates, Lusaka, Zambia.
Mulakwa KamuliwoNational Malaria Control Centre, Lusaka, Zambia.
Faustina N PhiriNational Malaria Control Centre, Lusaka, Zambia.
Lucy MuziaZambia Integrated Systems Strengthening Program, Abt Associates, Lusaka, Zambia.
Javan ChandaNational Malaria Control Centre, Lusaka, Zambia.
Alister KandyataNational Malaria Control Centre, Lusaka, Zambia.
Brian ChirwaZambia Integrated Systems Strengthening Program, Abt Associates, Lusaka, Zambia.
Kathleen PoerZambia Integrated Systems Strengthening Program, Abt Associates, Lusaka, Zambia.
Janet HemingwayVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Charles S WondjiVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Hilary RansonVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Michael ColemanVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine · GBNational HIV/AIDS/STI/TB Council · ZM

Funding

Wellcome Trust 101893
6 · The paper itself

Abstract

backgroundThere has been rapid scale-up of malaria vector control in the last ten years. Both of the primary control strategies, long-lasting pyrethroid treated nets and indoor residual spraying, rely on the use of a limited number of insecticides. Insecticide resistance, as measured by bioassay, has rapidly increased in prevalence and has come to the forefront as an issue that needs to be addressed to maintain the sustainability of malaria control and the drive to elimination. Zambia's programme reported high levels of resistance to the insecticides it used in 2010, and, as a result, increased its investment in resistance monitoring to support informed resistance management decisions. METHODOLOGY/PRINCIPAL

findingsA country-wide survey on insecticide resistance in Zambian malaria vectors was performed using WHO bioassays to detect resistant phenotypes. Molecular techniques were used to detect target-site mutations and microarray to detect metabolic resistance mechanisms. Anopheles gambiae s.s. was resistant to pyrethroids, DDT and carbamates, with potential organophosphate resistance in one population. The resistant phenotypes were conferred by both target-site and metabolic mechanisms. Anopheles funestus s.s. was largely resistant to pyrethroids and carbamates, with potential resistance to DDT in two locations. The resistant phenotypes were conferred by elevated levels of cytochrome p450s. CONCLUSIONS/SIGNIFICANCE: Currently, the Zambia National Malaria Control Centre is using these results to inform their vector control strategy. The methods employed here can serve as a template to all malaria-endemic countries striving to create a sustainable insecticide resistance management plan.

Indexed as

Mosquito ControlAcetylcholinesteraseAnimalsAnophelesDNAGene Expression RegulationGenes, InsectGenotypeGeographyInsecticide ResistanceInsecticidesInsect VectorsMolecular Sequence AnnotationMutationParasitesPhenotypeAcetylcholinesteraseDNAInsecticides

Identifiers

PMID24932861
PMCPMC4059741
OpenAlexW2027334075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.